请输入您要查询的百科知识:

 

词条 NatiVita
释义

  1. Pharmaceutical producing complex

  2. Scientific-research centre

  3. External links

  4. References

{{Orphan|date=August 2017}}{{Infobox company
| name = NatiVita
| logo = NatiVita's logo.png
| logo_size = 250px
| type = Public
| foundation = 2012
| key_people = [https://ej.by/rating/business2016/alexey-sychev.html Alexey Sychov] Chairman of the Board
| industry = Innovative medications research and developing
| homepage = {{URL|http://www.nativita.com/}}
}}NatiVita is an international research and manufacturing pharmaceutical company, it is situated in Beshankovichy urban settlement, Vitebsk region, Belarus. NatiVita is the first company in Belarus, that started developing and producing biopharmaceutical medicines based on monoclonal antibodies using target cell therapy for specific genetic diseases such as Breast cancer, Lung cancer, Myeloma.[1]

The company was established in 2012 with support of AB ZiaValda[2] (Lithuania), «UniPharma» (Slovakia), «NatcoPharma Ltd» (India)

Pharmaceutical producing complex

Pharmaceutical producing complex NatiVita has a full cycle of medicine’s production according to the European quality standard GMP[3] (Good Manufacturing Practice). There is the first in Belarus line for producing the cytostatic medicines in hard forms.

Scientific-research centre

The International Scientific-research centre Nativita was opened in 2017.[4] In laboratories of the centre several programs are being developed:

MABPOINT – developing of medicines on the base of monoclonal antibodies, for healing such diseases as breast and lung cancer, collateral cancer, pancreatic cancer, head and neck cancer, liver cancer, myeloblastosis.

CHEMMOTION – creation of the first in Belarus chemical generics and innovative medicines for healing diseases like multiple myeloma, lung cancer, breast cancer, lymphocytic leukaemia, prostate cancer.

As well the scientific-research centre together with partners realize scientific programs on the developing personified vaccine for healing breast cancer and lung cancer and adoption of the test-system for differential diagnosis of acute myoblast leucosis, defining prognoses and tactics of therapy.

External links

  • News from Belarus: Belarus can take its pharma industry to the next level
  • Sharkovshchina Regional Executive Committee: Slovakia takes live interest in pharmaceutical enterprise in Belarusian Beshenkovichi
  • Belarus Business News: Lithuanian private sector eyeing Belarusian pharmaceutics with interest

References

1. ^Pharmaceutical Industry in Russia, Ukraine, Belarus and Kazakhstan
2. ^The company was established in 2012 with support of AB ZiaValda
3. ^https://www.uniter.by/upload/iblock/725/725f5cc0f3323411be25ffb8f7a9e6be.pdf
4. ^The official opening ceremony of NatiVita research complex was held on July 13, 2017

2 : 2012 establishments in Belarus|Pharmaceutical companies of Belarus

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/17 14:55:44